Telesis Bio, Inc. TBIO
OTC PK
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -- | -36.96M | -45.24M | -47.72M | -38.17M |
| Total Depreciation and Amortization | -- | 3.24M | 4.20M | 4.16M | 3.89M |
| Total Amortization of Deferred Charges | -- | 610.00K | 722.00K | 765.00K | 793.00K |
| Total Other Non-Cash Items | -- | 15.91M | 16.89M | 17.01M | 5.42M |
| Change in Net Operating Assets | -- | 774.00K | -3.29M | -8.86M | -4.91M |
| Cash from Operations | -- | -16.42M | -26.72M | -34.65M | -32.98M |
| Capital Expenditure | -- | -828.00K | -1.98M | -1.95M | -2.46M |
| Sale of Property, Plant, and Equipment | -- | 0.00 | 0.00 | 0.00 | -- |
| Cash Acquisitions | -- | -- | -- | -- | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -3.65M | 4.35M | -3.81M | 1.42M |
| Cash from Investing | -- | -4.48M | 2.37M | -5.76M | -1.05M |
| Total Debt Issued | -- | -- | -- | -- | 0.00 |
| Total Debt Repaid | -- | -15.08M | -15.08M | -15.09M | -58.00K |
| Issuance of Common Stock | -- | 60.00K | 232.00K | 240.00K | 356.00K |
| Repurchase of Common Stock | -- | -12.00K | -12.00K | -- | -- |
| Issuance of Preferred Stock | -- | 1.00M | 19.41M | 19.41M | 18.41M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -1.12M | 7.01M | 7.01M | 7.99M |
| Cash from Financing | -- | -15.15M | 11.56M | 11.57M | 26.69M |
| Foreign Exchange rate Adjustments | -- | -9.00K | -9.00K | -3.00K | -16.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -36.06M | -12.81M | -28.85M | -7.35M |